Concepedia

Christin Tse

CT

20

Publications

5.2K

Citations

20

H-Index

1992

Active since

Affiliations

Abbott Fund(Current)

The University of Texas Health Science Center at San Antonio

Abbott (United States)

Abbott (United Kingdom)

Universitat de València

Christin Tse is an author at Abbott Fund specializing in medicine, oncology, and tumor biology.

Top concepts

Publications per year

1992–2015

20

Publications

20

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor

Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research · 2008 · 1.9K citations · Full text

Disruption of Higher-Order Folding by Core Histone Acetylation Dramatically Enhances Transcription of Nucleosomal Arrays by RNA Polymerase III

Christin Tse, Takashi Sera, Alan P. Wolffe et al. · Molecular and Cellular Biology · 1998 · 566 citations · Full text

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

H Zhang, J Chen, Sajid Khan Tahir et al. · Cell Death and Disease · 2015 · 427 citations · Full text

Bcl-2 family proteins are essential for platelet survival

H Zhang, Paul Nimmer, Stephen K Tahir et al. · Cell Death and Differentiation · 2007 · 414 citations · Full text

, , +8

Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737

Stephen K. Tahir, Xiufen Yang, Mark G. Anderson et al. · Cancer Research · 2007 · 301 citations

, , +14

Rows per page

1–5 of 20